Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point decrease » point increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point decrease » point increase (Expand Search)
-
2261
-
2262
-
2263
-
2264
-
2265
-
2266
-
2267
Column charts of WiAUC in therapy and control group at baseline and follow-up.
Published 2025Subjects: -
2268
SDI-based age-standardized rates of DALYs and ASDR for IHD attributable to HSBP.
Published 2025Subjects: -
2269
Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
Published 2024“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”
-
2270
Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
Published 2024“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”
-
2271
Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
Published 2024“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”
-
2272
-
2273
-
2274
-
2275
-
2276
-
2277
-
2278
-
2279
-
2280